The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/appi.ps.201800390

Abstract

Objective:

Guidelines recommend against prescribing antipsychotics without an indication, yet prescription rates remain undesirably high for youths. Information technology can facilitate guideline-based prescribing, but little is known about providers’ needs. The Safer Use of Antipsychotics in Youth project is implementing an algorithm-based workflow for peer consultation, care navigation, and expedited psychotherapy access. To optimize workflow for a multisite trial, we engaged providers for input.

Methods:

Guided by human-centered design, we interviewed 15 providers from Kaiser Permanente Washington and Nationwide Children’s Hospital about their prescribing barriers and workflow preferences. We identified qualitative themes on barriers affecting implementation and design opportunities to optimize workflow.

Results:

Providers expressed two major barriers: potential disruptions to clinical practice and threats to professional autonomy. Three design opportunities emerged: à la carte orders, passive review of orders, and consultation self-acknowledgment.

Conclusions:

Human-centered design offers an innovative approach to improve guideline-based prescribing with optimizations that are grounded in providers’ needs.

HIGHLIGHTS

  • Guidelines recommend against prescribing antipsychotics without an indication, yet prescription rates remain undesirably high for youths.

  • Information technology interventions designed to meet providers’ needs have the potential to facilitate guideline-based prescribing.

  • Human-centered design provides an innovative approach to identify and address barriers through workflow optimizations that inform intervention development.

Rates of prescribing antipsychotic medications to children and adolescents remain high (1, 2), despite guidelines against their use for behavioral symptoms of childhood mental disorders in the absence of approved indications (3). Most antipsychotic use in youths is for nonpsychotic conditions (e.g., attention-deficit hyperactivity disorder, disruptive behavior) (2, 4). Side effects can be severe and affect patients differently (5, 6). Lack of timely access to evidence-based psychotherapies leads to substitution with medication. For example, less than half of youths initiating an antipsychotic medication received psychosocial treatment in the previous 90 days (7). We need to improve the quality of prescribing and care received by youths.

To enhance guideline-based prescribing for youths, the Safer Use of Antipsychotics in Youth (SUAY) project is testing an algorithm-based workflow in a multisite pragmatic effectiveness trial. Developed by a national consensus panel of child and adolescent psychiatrists and developmental pediatricians, the proposed SUAY workflow (Figure 1) triggers peer consultation and care navigation, with expedited psychotherapy access for youths who have antipsychotic medication orders for nonpsychotic disorders. A related program in Washington requiring mandatory prescription review reduced antipsychotic use by half (8). However, the program’s “hard stops” on pharmacy refills is cumbersome for clinicians. SUAY seeks to streamline this workflow.

FIGURE 1.

FIGURE 1. Proposed workflow for the Safer Use of Antipsychotics in Youth projecta

aNew antipsychotic medication orders (i.e., excludes refills) or medication changes for youths ages 3–17 with disorders other than psychosis, mania, tics, autism spectrum, or moderate to severe intellectual disability trigger an alert. The alert recommends a real-time phone consultation with an expert child and adolescent psychiatrist, a one-time 72-hour medication supply, and referral to a care navigator to coordinate follow-up, with expedited access to evidence-based psychotherapy through a registry system.

Although technology can guide evidence-based prescribing (9), best practices for designing effective decision support are limited (10). Without meeting the needs of users, technology risks poor adoption, limited clinical integration and effectiveness, and unintended healthcare consequences (11). To optimize the proposed workflow, we engaged providers in human-centered design for input on guideline-based prescribing. Human-centered design is an informatics framework for optimizing information systems and services with formative input from health care stakeholders to produce useful technology that engenders adoption (12). SUAY “users” are prescribing providers who will incorporate the proposed workflow in their future practice.

Methods

We interviewed pediatric and adolescent providers to assess fit of the proposed workflow with their prescribing needs and practices. We recruited primary care providers, developmental behavioral pediatricians, advanced registered nurse practitioners, and psychiatrists with experience prescribing antipsychotics from Kaiser Permanente Washington and Nationwide Children’s Hospital. Kaiser Permanente Washington’s integrated health care system treats approximately 56,000 youths with behavioral health services. Nationwide Children’s Hospital treats approximately 31,000 youths annually with inpatient and outpatient behavioral health services. Both sites use the EpicCare electronic health record.

We conducted 1-hour audio-recorded interviews following a three-part guide: prescribing needs and barriers, elicited through critical incidents (13) by recounting prior prescribing experiences; design preferences for the proposed workflow, visually depicted with a storyboard (14) that we walked through using vignettes of fictitious patients for feedback across various clinical scenarios; and a demographic survey (see Appendix 1, which is available as an online supplement to this report). Institutional review board approval deemed study procedures exempt. Participants received $100.

We analyzed survey data with descriptive statistics and used thematic analysis (15) to qualitatively code interview recordings for themes about workflow barriers and design opportunities. Following Braun and Clarke (15), we first explored patterns across interviews. Subsequent coding focused on workflow reactions to alert-guided prescribing, considerations for peer consultation (e.g., timing), and characteristics of care navigation, from which themes emerged.

Results

Fifteen participants completed interviews, including six providers from Kaiser Permanente Washington and nine providers from Nationwide Children’s Hospital. Appendix 2 (see online supplement) summarizes participant characteristics.

Participants found value in standardizing antipsychotic prescribing. Several have unfettered access to expert consultants through call services, curbside meetings, preceptors, and other informal channels, so the proposed workflow was seen as potentially duplicative. However, the workflow was considered beneficial for formalizing consultative practices in the electronic health record. Most participants recognized added benefits of care navigation but felt it was not appropriate for every case. Despite these positive reactions, providers expressed two major barriers of the proposed workflow: potential disruptions to clinical practice and threats to professional autonomy.

First, real-time consultation, hard stops, and other features of the proposed workflow led to a concern about disrupting clinical practice by reducing care quality and causing delays and safety risks. Most participants were concerned about limited time to “squeeze” real-time consultation into packed schedules. Real-time consultation was not found practical nor necessary. Some felt that rushing the consultation could provide a “disservice” by limiting time for information gathering and thoughtful discussion. A couple of participants described alternative emergency services already in place for real-time consultation. There was consensus that a thorough and thoughtful consultation, which might require time outside of patient visits, was more important than efficiency.

Enforcing a hard stop for every antipsychotic order until documentation of the consultation also raised concern about care delays and safety, such as for immediate or emergency access to antipsychotics. As one participant commented, “So my concern would be, here I am I have done a thorough evaluation and this is well within my area of expertise and my only choice is an emergency prescription and I can’t reorder it until I consult with someone and document that was done—it’s extra steps, it’s extra time and it could be a delay in treatment.”

Others described needing to start or wean patients off antipsychotics to “bridge care” while waiting for therapy or specialty care. Although participants agreed emergency prescriptions help, they found 72 hours insufficient without override options when wait times are weeks to months. Consultation with a 14-day emergency prescription was seen as reasonable, depending on the urgency of the case and consultant availability.

We identified threats to professional autonomy as the second major barrier. Behavioral health providers with extensive prescribing experience shared concern about a blanket requirement for peer consultation, describing it as “aggravating,” “scrutinizing,” or even “offensive.” They saw little value in consultation for what was perceived as reasonable prescribing by experts with training in psychiatry and pediatrics. In contrast, primary care providers considered peer consultation “reassuring,” a “safety net” for inexperienced prescribers, and a resource rather than a barrier. As one participant noted, “Nobody likes to be told what to do, but everyone likes to be offered help!” A couple of primary care providers felt the workflow implicitly encouraged them to manage complex cases they would otherwise “punt” to psychiatry. Some felt the proposed workflow should provide a “happy medium” between monitoring and guiding practice given diversity in provider experience and patient cases. Rather than treating all providers the same (i.e., alert fires for all medication orders irrespective of clinical context), some participants suggested targeting peer consultation to those who most need it.

To address these barriers, participants suggested improvements, including training, information flows, and checklists to guide prescribing. One participant suggested design improvements to reduce disruptions, saying, “What if the workflow helped guide providers to consultation by making it easy to do the right thing, such as embedding the [consultation] referral in the alert and having a place for me to enter my phone number and best times for the consultant to call me?”

Another participant recommended prereview to flag only orders outside of guideline that require consultation: “Have the prescriber write up the plan. The consultant reviews and ok’s without needing a phone discussion except for the questionable cases.” Encouraging autonomy was also suggested: “[Design it] On the honor system, for people who don’t have that expertise, to encourage them to seek a consultation, especially if it is something they have not dealt with before and particularly if it is a behavioral health issue and they are not a behavioral health provider.”

Documentation from the consultant was valued for more than only a “yes” or “no” judgment, but rather a plan for management, expectations, next steps, and patient education. Given participants’ input, we identified three consistent design opportunities to optimize SUAY workflow: provide à la carte order sets in the alert to tailor available resources to varied needs, facilitate passive review of orders to minimize disruptions and target behavior change, and encourage self-acknowledgment of completed consultation to preserve professional autonomy (Appendix 3 in the online supplement).

Discussion

Using human-centered design, we solicited provider input to optimize SUAY workflow. Interviews identified two major barriers—clinical practice disruptions and threats to professional autonomy—that can be addressed through design improvements that providers recommended: à la carte orders, passive review, and self-acknowledgment of completed consultations. Because they are grounded in the needs and practices of future intervention users, these optimizations could improve adoption and effective use. We implemented these improvements for our multisite pragmatic trial.

Findings, based on interviews with a small number of providers focused on a specific prescribing scenario, have limited generalizability and may not fully translate to other clinical settings. Although we engaged prescribers from two health care systems, findings could reflect selection bias. Future work should further compare needs of behavioral health and primary care providers. Successful adoption of workflow optimization technology requires additional research to align system design with input from a larger sample of providers, staff, and patients. Despite these limitations, findings provide insight into complex clinical workflows and professional autonomy, which are valuable for implementing SUAY and guiding development of similar interventions.

Human-centered design offers an innovative approach to improve guideline-based prescribing. Providers’ input, which reflects the needs and preferences of future users, helped us arrive at a more acceptable solution with increased likelihood of adoption. Our work illustrates a structured process for negotiating difficult design choices in which systemwide charges and individual priorities may conflict. Human-centered design helped us engage providers in the formative design of our future system that will positively impact their work.

Department of Biomedical Informatics and Medical Education, School of Medicine, University of Washington, Seattle (Hartzler); Kaiser Permanente Washington Health Research Institute, Seattle (Ralston, Hannan, Penfold); Nationwide Children's Hospital, Abigail Wexner Research Institute, Center for Innovation in Pediatric Practice, Columbus, Ohio (Kelleher).
Send correspondence to Dr. Hartzler ().

This project was supported by National Institute of Mental Health (NIMH) contract number HHSN271201600002C (“A Targeted Approach to a Safer Use of Antipsychotics in Youth,” total award of $9,658,552).

No project costs were financed by nongovernmental sources. The content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by, NIMH or the National Institutes of Health.

Dr. Penfold reports receiving research funding from Janssen Pharmaceuticals. The other authors report no financial relationships with commercial interests.

References

1 Olfson M, Blanco C, Liu SM, et al.: National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry 2012; 69:1247–1256Crossref, MedlineGoogle Scholar

2 Penfold RB, Stewart C, Hunkeler EM, et al.: Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep 2013; 15:426Crossref, MedlineGoogle Scholar

3 American Psychiatric Association: Five Things Physicians and Patients Should Question. Philadelphia, Choosing Wisely, 2013. http://www.choosingwisely.org/doctor-patient-lists/american-psychiatric-association/Google Scholar

4 Loy JH, Merry SN, Hetrick SE, et al.: Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database Syst Rev 2012; 9:CD008559MedlineGoogle Scholar

5 Correll CU: Safety and tolerability of antipsychotic treatment in young patients with schizophrenia. J Clin Psychiatry 2011; 72:e26Crossref, MedlineGoogle Scholar

6 Cohen D, Bonnot O, Bodeau N, et al.: Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis. J Clin Psychopharmacol 2012; 32:309–316Crossref, MedlineGoogle Scholar

7 Finnerty M, Neese-Todd S, Pritam R, et al.: Access to psychosocial services prior to starting antipsychotic treatment among Medicaid-insured youth. J Am Acad Child Adolesc Psychiatry 2016; 55:69–76.e3Crossref, MedlineGoogle Scholar

8 Barclay RP, Penfold RB, Sullivan D, et al.: Decrease in statewide antipsychotic prescribing after implementation of child and adolescent psychiatry consultation services. Health Serv Res 2017; 52:561–578Crossref, MedlineGoogle Scholar

9 Garg AX, Adhikari NK, McDonald H, et al.: Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 2005; 293:1223–1238Crossref, MedlineGoogle Scholar

10 Horsky J, Schiff GD, Johnston D, et al.: Interface design principles for usable decision support: a targeted review of best practices for clinical prescribing interventions. J Biomed Inform 2012; 45:1202–1216Crossref, MedlineGoogle Scholar

11 Ash JS, Sittig DF, Dykstra R, et al.: The unintended consequences of computerized provider order entry: findings from a mixed methods exploration. Int J Med Inform 2009; 78:S69–S76Crossref, MedlineGoogle Scholar

12 Johnson CM, Johnson TR, Zhang J: A user-centered framework for redesigning health care interfaces. J Biomed Inform 2005; 38:75–87Crossref, MedlineGoogle Scholar

13 Flanagan JC: The critical incident technique. Psychol Bull 1954; 51:327–358Crossref, MedlineGoogle Scholar

14 Truong KN, Hayes GR, Abowd GD: Storyboarding: An empirical determination of best practices and effective guidelines; in DIS ‘06: Proceedings of the 6th conference on Designing Interactive systems (pp. 12–21). Edited by Carroll JM, Bødker S, Coughlin J. University Park, PA, Association for Computing Machinery, 2006Google Scholar

15 Braun V, Clarke V: Using thematic analysis in psychology. Qual Res Psychol 2006; 3:77–101CrossrefGoogle Scholar